Presentation is loading. Please wait.

Presentation is loading. Please wait.

Corporate Presentation INDOCO REMEDIES LTD. About Us  Indian Company with an International presence  Turnover 09-10; Rs. 402.36 Crores  Among the fastest.

Similar presentations


Presentation on theme: "Corporate Presentation INDOCO REMEDIES LTD. About Us  Indian Company with an International presence  Turnover 09-10; Rs. 402.36 Crores  Among the fastest."— Presentation transcript:

1 Corporate Presentation INDOCO REMEDIES LTD

2 About Us  Indian Company with an International presence  Turnover 09-10; Rs Crores  Among the fastest growing Indian Companies  Ranked 22nd in ORG IMS Rx Audit on MAT basis (ORG July 2010)  Complete solution provider  CRAMS – R&D, Regulatory & Mfg  USFDA & MCC SA approved sterile eye drops facility  UK MHRA, German Darmstad, ANVISA Brazil, MCC SA approved tablets, creams & capsules facility  R&D and Regulatory capabilities  Employs 3000 people  100 R&D scientists  1700 field staff

3 Our Infrastructure  Corporate Office  Manufacturing Facilities  5 Formulations facilities  2 API facilities  R&D Centre  Depots & Branches  34 Branches  Domestic Marketing Network  7 divisions  PAN INDIA presence

4 Our Business  Indian Business  Branded Generic Formulations  APIs  International Business  Regulated Markets  Generics  CRAMS  APIs  Emerging Markets  Branded Generic Formulations  APIs

5 Indian Business  INDOCO – GP, CP, Gynaec, Life Style  SPADE – GP, CP, Paediatrician  WARREN – Dental, ENT  EXCEL – Opthal, ENT  SPERA – GP, Gynaec, Paediatrician  XTEND – GPs in Extra Urban Towns  ETERNA – CPs, Orthos, Gastro

6 International Presence- FY10

7 Formulations Infrastructure SITEDOSAGE FORMSTATUS GOA ITABLETSUK MHRA, GERMAN BRAZIL ANVISA, MCC SA, TGA CREAMS & OINTMENTSUK MHRA GOA IISTERILE EYEDROPSUS FDA, MCC SA GOA IIITABLETSUK MHRA, GERMAN BRAZIL ANVISA, MCC SA, TGA PILOT TABLET CAPSULES WALUJTABLETSROW BADDITABLETS & LIQUID ORALSSCHEDULE M UK MHRA, TGA CREAMS & OINTMENTS TOOTHPASTES

8 API Infrastructure  KILO PLANT  Reaction Systems: 16 to 500 L  Total Reactor Volume: 1 cubic meters  Temperatures range: -55 to celsius  MULTI-TON PLANT  Reactor Capacity: 500 to 4000 L  Total Reactor Volume: 55 cubic meters  NEW OPHTHALMIC FACILITY  Reactor Capacity: 500 to 2000 L  Total reactor Volume: 15 cubic meters  INTERMEDIATES FACILITY  Reactor Capacity: 500 to 4000 L  Total Reactor Volume: 50 cubic meters

9 R & D  The state-of-art, stand alone, US $ 8 million R & D center for Formulations, API & Intermediates is located at Rabale- near New Mumbai  The R & D center in a area of 70,000 Sq.feet is designed to accommodate more than 200 scientists and technical personnel  This center is equipped with all required sophisticated hardware and software  The state of art cGMP standard KILO LAB is a part of this Research Center

10 R & D F&D Regulatory API Research

11 F & D NDDS GENERICS CONTRACT RESEARCH CONTRACT MFG DOMESTIC PIPELINE  Over 50 Scientists working estimated to go up to 75 next year.  Launched 12 new products during last year  Completed 20 and currently working on 19 euro dossiers and completed 5 and working on 18 ANDA projects. These are Indoco’s own IP.  Filed 4 ANDAs for various US partners  926 Formulation Dossiers of 161 products submitted to 54 countries & 20 products are under preparation for 13 countries.  Executing contracts for Development work for International Companies. Multiple site transfer projects and Euro Dossiers completed to the satisfaction of the European Customers.

12 API ( R&D) CONTRACT RESEARCH CUSTOM SYNTHESIS GENERICS API R&D SYNTHETIC CHEMISTRY SCALE UPIPRANALYTICALKILO LAB

13 Regulatory 8 USDMF 1 DMF for Canada 4 EU DMF / COS under preparation 5 COS 13 APIs open part of DMF submitted to Emerging Markets REG AFFAIRS API US DMF JDMFCOS EU DMF

14 Regulatory Submitted 20 dossiers to various customers in Europe, New Zealand, Australia & SA 19 in Pipeline 5 ANDAs submitted 3 ANDAs under preparation 14 ANDAs in pipeline REG AFFAIRS ANDACTDDOSSIERS

15 CRAMS

16 Performance Highlights  Integrated player  R&D, Manufacturing & Marketing in both API & Formulations  Strong presence in India  Ranked 22nd in Rx Audit (IMS ORG)  Ranked 31st in Retail Audit (IMS ORG)  Focussed on exports  International Sales estimated to grow more than 40%  Partnering

17 Growth Drivers Present domestic marketing set up Focus on high value products such as anti infective, GI products, etc. Intensive Pan – India coverage of medical fraternity through various marketing divisions. Partnering with Watson and Aspen Strong R&D Set up New Plants at Goa and Waluj

18 Discussion Session

19 Thank you very much


Download ppt "Corporate Presentation INDOCO REMEDIES LTD. About Us  Indian Company with an International presence  Turnover 09-10; Rs. 402.36 Crores  Among the fastest."

Similar presentations


Ads by Google